- Report
- May 2025
- 124 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 193 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 371 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- November 2024
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- August 2024
- 80 Pages
Global
From €1310EUR$1,500USD£1,138GBP
- Report
- May 2023
- 193 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- February 2024
- 179 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- April 2023
- 180 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2023
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- August 2024
- 135 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- August 2024
- 185 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- October 2023
- 90 Pages
United States
From €3057EUR$3,500USD£2,655GBP
- Report
- June 2023
- 116 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- February 2024
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP

The Microbiome Sequencing market is a subset of the biotechnology industry that focuses on the sequencing of microbial genomes. This technology is used to identify and characterize the microbial communities that inhabit the human body, as well as the environment. It is used to study the role of the microbiome in health and disease, and to develop new treatments and diagnostics. Microbiome sequencing is also used to identify and characterize microbial communities in food, water, and soil.
The microbiome sequencing market is expected to grow rapidly in the coming years, driven by increasing investments in research and development, and the growing demand for personalized medicine. Additionally, the increasing prevalence of chronic diseases and the need for better diagnostics and treatments are expected to drive the market.
Companies in the microbiome sequencing market include Illumina, Inc., Qiagen, Thermo Fisher Scientific, Inc., BGI, Eurofins Scientific, F. Hoffmann-La Roche Ltd., and Pacific Biosciences of California, Inc. Show Less Read more